January 20, 2023
Speaking of semaglutide…
Semaglutide seems to be everywhere. News stories in The Wall Street Journal. Vanity Fair. The New York Times.
Which reminds us to remind you about our Prescriber Brief about the rules and regs governing the compounding of peptides. You can find it here. (You’ll need your member login and password to access it.) Share it with the prescribers you work with. Maybe use it as a refresher for your own team members.
And while you’re at it, check out our Prescriber Brief on the regulatory framework that governs pharmacy compounding.
